Disposition of maternal ketoconazole in breast milk

Myla E. Moretti; Shinya Ito; Gideon Koren

doi:10.1016/0002-9378(95)90662-2

Disposition of maternal ketoconazole in breast milk

Myla E. Moretti, Shinya Ito, Gideon Koren

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

Infant exposure to ketoconazole in human milk was calculated to be 0.4% on average (maximum 1.4%) of those extracted from therapeutic doses given directly to infants. Potential risks of adverse reactions from this low exposure level seem to be outweighed by the benefits of breast-feeding.

Original language	English
Pages (from-to)	1625-1626
Number of pages	2
Journal	American Journal of Obstetrics and Gynecology
Volume	173
Issue number	5
DOIs	https://doi.org/10.1016/0002-9378(95)90662-2
State	Published - 1995
Externally published	Yes

Keywords

Ketoconazole
breast milk
breast-feeding
human milk

Access to Document

10.1016/0002-9378(95)90662-2

Cite this

@article{21f65e26c756416abdc9ba1b6419ef2e,

title = "Disposition of maternal ketoconazole in breast milk",

abstract = "Infant exposure to ketoconazole in human milk was calculated to be 0.4\% on average (maximum 1.4\%) of those extracted from therapeutic doses given directly to infants. Potential risks of adverse reactions from this low exposure level seem to be outweighed by the benefits of breast-feeding.",

keywords = "Ketoconazole, breast milk, breast-feeding, human milk",

author = "Moretti, \{Myla E.\} and Shinya Ito and Gideon Koren",

year = "1995",

doi = "10.1016/0002-9378(95)90662-2",

language = "אנגלית",

volume = "173",

pages = "1625--1626",

journal = "American Journal of Obstetrics and Gynecology",

issn = "0002-9378",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Disposition of maternal ketoconazole in breast milk

AU - Moretti, Myla E.

AU - Ito, Shinya

AU - Koren, Gideon

PY - 1995

Y1 - 1995

N2 - Infant exposure to ketoconazole in human milk was calculated to be 0.4% on average (maximum 1.4%) of those extracted from therapeutic doses given directly to infants. Potential risks of adverse reactions from this low exposure level seem to be outweighed by the benefits of breast-feeding.

AB - Infant exposure to ketoconazole in human milk was calculated to be 0.4% on average (maximum 1.4%) of those extracted from therapeutic doses given directly to infants. Potential risks of adverse reactions from this low exposure level seem to be outweighed by the benefits of breast-feeding.

KW - Ketoconazole

KW - breast milk

KW - breast-feeding

KW - human milk

UR - https://www.scopus.com/pages/publications/0028825999

U2 - 10.1016/0002-9378(95)90662-2

DO - 10.1016/0002-9378(95)90662-2

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 7503214

AN - SCOPUS:0028825999

SN - 0002-9378

VL - 173

SP - 1625

EP - 1626

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

IS - 5

ER -

Disposition of maternal ketoconazole in breast milk

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this